Airsculpt Technologies, Inc. (AIRS) stock
AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3083% below fair value
$0.65−0.06 (-8.87%)
Close on Nov 19, 2026Market cap $47.17MP/E –Yield –
Airsculpt Technologies free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Airsculpt Technologies's free cash flow for the twelve months ending Jun 30, 2026 was $760.00K. For fiscal 2025 it was $692.00K. The highest annual figure on record is $19.52M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $692.00K | – |
| FY2024 | Dec 31, 2024 | -$2.66M | -118.9% |
| FY2023 | Dec 31, 2023 | $14.04M | +21.8% |
| FY2022 | Dec 31, 2022 | $11.53M | -40.9% |
| FY2021 | Dec 31, 2021 | $19.52M | +90.1% |
| FY2020 | Dec 31, 2020 | $10.27M | +1957.7% |
| FY2019 | Dec 31, 2019 | $499.00K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.47M | -131.1% |
| Q1 FY2026 | Mar 31, 2026 | $5.22M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.59M | – |
| Q3 FY2025 | Sep 30, 2025 | -$405.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $4.72M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.03M | -157.3% |
| Q4 FY2024 | Dec 31, 2024 | -$815.00K | -126.8% |
| Q3 FY2024 | Sep 30, 2024 | -$3.07M | – |
| Q2 FY2024 | Jun 30, 2024 | -$576.00K | -105.7% |
| Q1 FY2024 | Mar 31, 2024 | $1.80M | -25.0% |
| Q4 FY2023 | Dec 31, 2023 | $3.04M | -31.6% |
| Q3 FY2023 | Sep 30, 2023 | -$1.48M | – |
| Q2 FY2023 | Jun 30, 2023 | $10.08M | +18.1% |
| Q1 FY2023 | Mar 31, 2023 | $2.40M | -14.3% |
| Q4 FY2022 | Dec 31, 2022 | $4.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.26M | -161.3% |
| Q2 FY2022 | Jun 30, 2022 | $8.53M | -34.8% |
| Q1 FY2022 | Mar 31, 2022 | $2.81M | -63.0% |
| Q4 FY2021 | Dec 31, 2021 | -$8.10M | – |
| Q3 FY2021 | Sep 30, 2021 | $6.95M | – |
| Q2 FY2021 | Jun 30, 2021 | $13.08M | – |
| Q1 FY2021 | Mar 31, 2021 | $7.59M | – |
See a number that looks wrong?